We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Breakthrough POC Diagnostic Technology Detects Brain Abnormalities Prior to Symptoms

By HospiMedica International staff writers
Posted on 22 Oct 2022
Print article
Image: Delphi-MD Neurodiagnostics Device (Photo courtesy of QuantalX)
Image: Delphi-MD Neurodiagnostics Device (Photo courtesy of QuantalX)

According to a study published in "The Lancet", 90% of strokes and 35% of dementias can be prevented if detected early enough, however diagnosis methods available today result in ineffective treatment of brain disorders due to late, inaccurate and under diagnosis. Additionally, 35% of the total economic disease burden is attributed to brain disorders, mostly due to repeated hospitalization and rehabilitation, avoidance of unnecessary CT/MRI scans and associated accessibility and cost challenges. Now, the world's first direct brain network visualization technology provides objective clinical measurements of neuronal functions for the first time, enabling point of care physicians and neurologists access to new diagnostics capabilities.

Quantalx Neuroscience, Inc. (Raanana, Israel) has developed Delphi-MD, an "ECG" for the brain, which provides direct brain network visualization, enabling clinical measurements of neuronal functions for the first time in healthcare history. For clinicians, such a brain health revolutionizing technology, accessible at the point of care, dramatically supports early and differential diagnosis through "real life" objective data, leading to informed treatment decisions and interventions, as well as improving brain health outcomes for healthcare providers and payors. For patients, an earlier diagnosis leads to an optimal care pathway, resulting in a positive, long-term effect on quality of life.

"The clinical breakthrough of Delphi-MD is that it is a direct, functional, objective test for the brain, that does not require patient participation and provides actionable insight to the physician at the point of care," said Dr. Iftach Dolev, CEO and Co-Founder of QuantalX. "Making neuro-diagnosis accessible to everyone is game changing for brain health management"

Related Links:
QuantalX Neuroscience, Inc.

Gold Supplier
Premium Ultrasound Scanner
ARIETTA 850
New
Double Roller Pump for Arthroscopy
ARTHRO
New
Digital Physician's Model
WB-3000
New
Patient Management System
LIFENET System

Print article
Radcal

Channels

AI

view channel
Image: The WHO has conditionally recommended the use of algorithms in assisting with pediatric tuberculosis diagnosis (Photo courtesy of Pexels)

New Evidence-Based Algorithms Could Improve Diagnosis of Pediatric Tuberculosis

Tuberculosis (TB) continues to be one of the most prevalent causes of death among younger populations worldwide. Research indicates that over 96% of the deadly TB cases in children under the age of 15... Read more

Surgical Techniques

view channel
Image: Lighting up tumors could help surgeons remove them more precisely (Photo courtesy of Pexels)

‘Molecular Imaging’ Lights up Tumors for Surgeons to Enable Precise Removal

Neuroblastoma is a devastating form of childhood cancer that accounts for 8-10% of all childhood cancers and roughly 15% of all childhood deaths from cancer. Sadly, in almost one-third of cases, the cancer... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Business

view channel
Image: The demand for endometrial ablation devices is increasing due to rising prevalence of gynecological disorders (Photo courtesy of Pexels)

Global Endometrial Ablation Market Driven by Rising Prevalence of Gynecological Disorders

Gynecological disorders, such as menorrhagia, PCOD, abnormal vaginal bleeding, affect millions of women globally every year and are on the rise. Abnormal Uterine Bleeding (AUB) is the most common disorder... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.